Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 220   

Articles published

PFE 33.74 +0.10 (0.30%)
price chart
Pfizer Inc. (PFE): Mid-Term Estimates Modestly Lowered
Jefferies sees a weaker than expected revenue performance for Pfizer Inc. (NYSE:PFE) in Q1'17. With subpar revenue and EPS CAGRs of 3% and 7%, respectively (2016A-2021E), Jefferies expects that management will step up business development to ...
Pfizer Inc (NYSE:PFE) Excited By The Positive Chmp's Opinion On Trumenba As A ...
Pfizer Inc (NYSE:PFE) has today made an announcement to inform all the concerned parties about the decision by the European Medicines Agency's Committee for Medicinal Products for Human Use to grant marketing authorization in the European Union ...
Pfizer Inc. Posted losses of -0.85% in the Last Trade  Free Observer
Pfizer Inc.: PSI And Pfizer Partner To Address Hypertension In Vietnam And Myanmar
The international nonprofit organization Population Services International (PSI) and the biopharmaceutical company Pfizer Inc. (NYSE:PFE) today announced Healthy Communities, a US $1 million collaboration to expand access to life-saving hypertension ...
Pfizer Inc. (PFE): Getting Technical With The Stock
With all other things going on, Pfizer Inc. (NYSE:PFE) has been on a run - rising 6.96 percent in just three months. It looks like traders are happy with the stock.
Pfizer Inc. (PFE) Exposed Via Its Technical Chart
Pfizer Inc. (PFE) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching PFE.
Better Buy: AbbVie Inc. vs. Pfizer
The bright side is that Pfizer does dole out a better than average dividend with a yield of 3.75%, and it has an absolute boatload of cash to execute additional value-creating deals going forward.
Pfizer Isn't Just A Dividend Stock
Pfizer has produced one of the most effective buybacks in this market. The company's spending has been in the tens of billions, but it has also reduced the float by a fifth in the past five years.
Pfizer subpoenaed in US intravenous saline solution probe
The drugmaker disclosed the subpoenas in a statement on Wednesday after ICU Medical Inc, which recently acquired Pfizer's global infusion therapy business, and Baxter International Inc said they received similar subpoenas. ICU Medical said the probe ...
These stock's might change the kismet of Investors: Pfizer Inc. (PFE), Immune ...
Pfizer Inc. (NYSE:PFE) closed at $33.74 a share in the latest session and the stock value rose almost 4.94% since the beginning of this year.
Most dynamic stock update: Pfizer Inc. (PFE), United States Steel Corporation (X)
On the close of 04/21/2017 Pfizer Inc. (NYSE:PFE) dropped -0.30% to hit $33.64. During the session shares stayed in the range from $33.73 to $33.47.